Engerix-b pedi 10 MCG/0.5 syrn 0.5ML

Ended Awarded Last action

Contract number
SPE2DR26FW4MV
Awardee
Awarding agency
Obligated
$17,260

Award facts

Contract value 100% obligated
$17,259.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 23, 2026, for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine with a ceiling value of $17,259.60 under firm fixed-price terms.

Place of performance is Conshohocken, PA. The order is issued under the parent DLA Troop Support Medical Indefinite Delivery Contract valued at $999,999,999.00 through December 2026, which covers pharmaceutical products and medical supplies to support military healthcare programs worldwide. Ultimate completion date is February 24, 2026. No set-aside was used.

Quick answers

Who was awarded contract SPE2DR26FW4MV?

SPE2DR26FW4MV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 23, 2026.

How much is contract SPE2DR26FW4MV worth?

The government has obligated $17,260 on SPE2DR26FW4MV.

Is contract SPE2DR26FW4MV an order under another contract?

Yes. SPE2DR26FW4MV is a delivery order under SPE2DR25D7067, an indefinite delivery contract.

Was contract SPE2DR26FW4MV competed?

The extent of competition for SPE2DR26FW4MV was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award